BC has four major subtypes according to the presence or absence of the three standard molecular markers (estrogen or progesterone receptors and HER2): HR + /HER2 − , HR + /HER2 + , HER2-enriched (HR − and HER2 +), and triple-negative (absence of the three standard molecular markers)7. This evidence concerns the gene ERBB2 and breast cancer.